Blue Cross, Others Booted In Pfizer Neurontin MDL
A judge on Friday threw out the bulk of claims brought by consumers, insurers and others in a consolidated class action alleging Pfizer Inc. and Warner-Lambert Co. fraudulently marketed the drug...To view the full article, register now.
Already a subscriber? Click here to view full article